Strategic Vaccine Ops Lonza is actively advancing room-temperature stable, spray-dried formulations of mRNA vaccines and has a strategic collaboration with Ethris. This indicates ongoing demand for scalable biologics manufacturing, formulation development, and cold-chain independent delivery solutions that you can align with through process development, analytical support, and supply chain optimization services.

Digital & Automated The company leverages modern digital tools and integration across SAP Business Technology Platform, Azure Databricks, MODA-EM integration with Rapid Micro Biosystems, and paperless microbial enumeration. This creates opportunities to offer advanced manufacturing IT, data analytics, compliance, and automation solutions that reduce cycle times and improve data integrity.

Global CDMO Leader Lonza positions itself as a premier, large Western CDMO with a global footprint and lean manufacturing focus. This suggests opportunities to provide scalable manufacturing technologies, supply chain resilience solutions, and co-development partnerships for complex biologics and cell and gene therapies across multiple sites.

Talent & Apprenticeships Recent biomanufacturing apprenticeship programs and leadership hires (Chief Legal & Corporate Affairs Officer) signal ongoing workforce development and compliance investments. This opens doors for training partnerships, continuous improvement programs, and scalable staffing models for expanding manufacturing capacity.

Strategic Partnerships Recent collaborations with IBM for data-driven material and supply chain insights, plus digital tooling integrations, point to a strong openness to co-innovation and external partnerships. This creates avenues for joint ventures, data services, and technology-enabled process optimization offerings.